Research & Development



  雲瑯頹然的倒在床上,哀嘆一聲道︰“真是豈有此理啊!!”   雲瑯起身深深一禮道︰“多謝先生提醒,小子絕對不會胡思亂想。”超碰在线视频Ca0P0rn97   郭解嘿嘿一笑,從懷里掏出一個皮口袋,隨便晃蕩兩下,里面裝的銅錢就嘩啦啦作響。超碰免费公开视频   雲瑯笑道︰“欲望啊,劉陵有著極為強烈的欲望,她想成為匈奴人的女王,有了這個欲望存在,她知道,她今天吃的苦,受到的屈辱,在某一天終將會成為她皇冠上最燦爛的光芒!”   哼,這才是騎都尉迅速離去的原因所在,他們不願意綁在我們這群老朽身上,另闢蹊徑的開拓了河曲城。超碰97资源站   別人對這種《陰符書》寫法是什麼反應不知道,反正衛青是如獲至寶,再三叮囑雲瑯不得說出去,除過霍去病,曹襄都不能告訴。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo